首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1509220

配药药局市场：依产品类型、依治疗领域、依应用、按地区

Compounding Pharmacies Market, By Product Type, By Therapeutic Area, By Application, By Geography

出版日期: 2024年05月29日 | 出版商:

Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024年全球复方製药市场价值为111.8亿美元，预计到2031年将达到169.2亿美元，2024年至2031年复合年增长率为6.1%。

图 1. 2024 年按地区分類的配药市场占有率(%)

由于复杂病理的个人化药物需求不断增长，预计全球复合製药市场将在预测期内呈指数级增长。当没有美国食品药物管理局(FDA)核准的处方笺药时，复方药房会根据患者的特定临床需求，组合和修改成分来生产定製药品。这些可以帮助满足精确的剂量要求或专门的配方，例如针对无法吞嚥固态锭剂的儿童或老年患者的药物。此外，它还允许药剂师创造具有独特口味和给药途径的药物，从而扩大治疗选择。越来越多的老年人被诊断出患有慢性疾病，这推动了对组合药物的需求。

市场动态：

由于全球需要客製化药物的慢性病发病率不断增加，全球复合製药市场正在稳步成长。此外，不断增加的老年人口通常需要专门的配方和剂型，这是市场成长的驱动力。复方药局相对于非处方药的优势，如专有剂型、儿科剂型以及满足患者特定需求的能力，也正在推动市场成长。然而，组合药物严格的法规结构和品质标准可能会阻碍市场成长。昂贵的商业同类产品的可用性也可能阻碍市场成长。新兴国家医疗保健支出的增加以及先进复合技术的利用可能为市场成长提供有利可图的机会。

本研究的主要特点

该报告对全球配药药品市场进行了详细分析，并提供了以 2023 年为基准年的预测期（2024-2031 年）的市场规模（十亿美元）和复合年增长率（CAGR%）。
它揭示了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
它根据公司亮点、产品系列、主要亮点、财务业绩和策略等参数，对全球製药市场的主要企业进行了介绍。
主要公司包括 Avella Specialty Pharmacy、Central Admixture Pharmacy Services、Fagron、Fresenius Kabi AG、PharMEDium Services、Institutional Pharmacy Solutions、Cantrell Drug Company、TriangleCompounding Pharmacies、Lorraine's Pharmacy、Rx3, PharmacyPharm、Birin SE ITC 复方药房和高级药房。
据信，这份报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球製药市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过分析全球製药市场时所使用的各种策略矩阵来促进决策。

公司简介
- Avella Specialty Pharmacy
- Central Admixture Pharmacy Services
- Fagron
- Fresenius Kabi AG
- PharMEDium Services
- Institutional Pharmacy Solutions
- Cantrell Drug Company
- Triangle Compounding Pharmacies
- Lorraine's Pharmacy
- Rx3 Compounding Pharmacy
- B Braun SE
- Clinigen Group PLC
- QuVa Pharma
- ITC Compounding Pharmacy
- Advanced Pharmacy
- Myonex

第10章分析师建议

命运之轮
分析师观点
Coherent Opportunity Map

第十一章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI3199

Global compounding pharmacies market is estimated to be valued at USD 11.18 Bn in 2024 and is expected to reach USD 16.92 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.

Figure 1. Compounding Pharmacies Market Share (%), By Region, 2024

Global compounding pharmacies market is expected to witness growth exponentially over the forecast period, owing to rising demand for personalized medications for complex conditions. Compounding pharmacies combine or alter ingredients into customized formulations as per patient's specific clinical needs when an U.S. Food and Drug Administration approved prescription product is not available. These help to cater accurate dosing requirements and particular formulations like medications for pediatric or geriatric patients who cannot swallow solid pills. Moreover, the ability of compounders to produce medications with unique flavors and routes of administration expands treatment options. Growing geriatric population diagnosed with chronic health conditions boosts demand for compounded medications.

Market Dynamics:

Global compounding pharmacies market is witnessing robust growth due to increasing incidence of chronic medical conditions worldwide requiring customized medications. Moreover, growing geriatric population base that often need specialized formulations and dose forms of drugs can drive the market growth The advantages of compounding pharmacies over commercially available drugs including unique dosage forms, pediatric dose forms, and ability to cater to patient-specific needs can also drive the market growth. However, strict regulatory framework and quality standards for compounded drugs can hamper the market growth. The availability of expensive commercial equivalents can also hamper the market growth. Increasing healthcare expenditure in emerging nations and utilization of advanced technologies in compounding can offer lucrative opportunities for the market growth.

Key Features of the Study:

This report provides an in-depth analysis of the global compounding pharmacies market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global compounding pharmacies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Fagron, Fresenius Kabi AG, PharMEDium Services, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacies, Lorraine's Pharmacy, Rx3 Compounding Pharmacy, B Braun SE, Clinigen Group PLC, QuVa Pharma, ITC Compounding Pharmacy, Advanced Pharmacy.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global compounding pharmacies market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compounding pharmacies market.

Detailed Segmentation-

By Product Type:
- Oral
- Capsule
- Tablets
- Mixtures
- Lollipops
- Lozenges
- Topical
- Gels
- Ointments
- Cream
- Lotions
- Rectal
- Nasal
- Ophthalmic
By Therapeutic Area:
- Hormone Replacement Therapy
- Pain Management
- Specialty Drugs
- Nutritional Supplements
- Others
By Application:
- Pediatric
- Adults
- Geriatrics
- Veterinary
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Avella Specialty Pharmacy
- Central Admixture Pharmacy Services
- Fagron
- Fresenius Kabi AG
- PharMEDium Services
- Institutional Pharmacy Solutions
- Cantrell Drug Company
- Triangle Compounding Pharmacies
- Lorraine's Pharmacy
- Rx3 Compounding Pharmacy
- B Braun SE
- Clinigen Group PLC
- QuVa Pharma
- ITC Compounding Pharmacy
- Advanced Pharmacy

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Compounding Pharmacies Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Compounding Pharmacies Market, By Product Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Capsule
Tablets
Mixtures
Lollipops
Lozenges
Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Gels
Ointments
Cream
Lotions
Rectal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nasal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ophthalmic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Compounding Pharmacies Market, By Therapeutic Area, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hormone Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nutritional Supplements
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Compounding Pharmacies Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Pediatric
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Adults
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Geriatrics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Veterinary
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Compounding Pharmacies Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Avella Specialty Pharmacy
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Central Admixture Pharmacy Services
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fagron
- Fresenius Kabi AG
- PharMEDium Services
- Institutional Pharmacy Solutions
- Cantrell Drug Company
- Triangle Compounding Pharmacies
- Lorraine's Pharmacy
- Rx3 Compounding Pharmacy
- B Braun SE
- Clinigen Group PLC
- QuVa Pharma
- ITC Compounding Pharmacy
- Advanced Pharmacy
- Myonex

10. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

配药药局市场：依产品类型、依治疗领域、依应用、按地区